Dublin, May 08, 2018 (GLOBE NEWSWIRE) -- The "Stem Cells in Drug Discovery & Toxicity Screening 2018" conference has been added to ResearchAndMarkets.com's offering.

Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.

Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Agenda:

• 3D-Cell Culture Based Models
• Technologies in 3D-Cell Culture
• iPSC-derived Cells for Toxicity Testing & Screening
• Screening Technologies, Instrumentation and Reagents
• Stem Cells in Drug Discovery and Development
• Use of Microfluidics Organs-on-Chips for Toxicity Screening

Keynote Speakers

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh

James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos

Gary Gintant
Research Fellow, Abbvie

Confirmed Speakers to Date

Ulrich Broeckel
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin

Guohao Dai
Associate Professor, Department of Bioengineering, Northeastern University

Toshihiko Ezashi
Research Associate Professor, The University of Missouri

Kennedy Okeyo
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Daniele Zink
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)

For more information about this conference visit https://www.researchandmarkets.com/research/ndptbs/stem_cells_in?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Drug Discovery, Drug Abuse Screening, Stem Cells 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.